How academic labs can approach the drug discovery process as a way to synergize with big pharma.

Abstract

While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases. 
DOI: 10.1016/j.tim.2013.03.006

Topics

  • Presentations referencing similar topics